Planing to attend? Save $700 on your ticket with super early-bird pricing ($800) + 3-for-the-price-of-2 group packs available. Offer ends in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The next generation of drug product development
and manufacturing technology is here…
Now in it’s 11th year, the popular 2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing returns this May.
Connect with 160+ senior drug development innovators and uncover industry’s latest formulation, product development and delivery technologies for improving performance and manufacuring capabilities.
2025’s Summit covers Controlled & Modified Drug Release, Drug Bioavailability Enhancement and Continuous Manufacturing technologies and capabilities.Â
✅ 2 full tracks of technical talks, panels and thought-provoking discussion sessions
✅ Network with 100’s of senior development, formulation and manufacturing attendees and solution providers
✅ Multiple exhibits, banquet lunches and dinners, workshops, exhibits, champagne giveaways and networking receptions
✅ Access all sessions post-Summit on-demand so you can relive your best moments
✅ Be part of our community of drug product development experts which will open many doors in the future.
40+
Industry-led Speakers
160+
Senior Attendees
2
Tracked Streams
14+
Networking Hours
18
Solution Providers
Controlled and Modified Release
- Oral Drug Delivery Systems
- Long Acting Injectable Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Modified release coating systems
- Biodegradable and Biocompatible Polymers
- Nanotechnology in Controlled Release
- Pulmonary Drug Delivery Systems
- The Role of Controlled Release in Optimizing Therapeutic Outcomes
- Patient Centric / Pediatric Dose Development
- 3D Printing in Controlled and Modified Release
- Regulatory considerations
- Continuous manufacturing of Controlled and Modified Release products
- Continuous modified release coating systems
- Continuous long-acting microsphere manufacturing
Bioavailability Enhancement
- Formulation strategies for improved absorption of poorly soluble and/or poorly permeable drugs
Solubility and dissolution enhancement techniques:
– Lipid-Based formulations
– Micronization
– Nanomedicine
– Nanocarriers
– Spray Dried Dispersions (SDD)
– Hot Melt Extrusion (HME)
– Kinetisol - Biopharmaceutics classification system (BCS) and its implications
- In vitro-in vivo correlations (IVIVCs)
- Continuous manufacturing technologies for Bioavailability Enhancement
Continuous Manufacturing
- Continuous biopharmaceutical manufacturing
- Continuous manufacturing of oral solids
- Spray Drying and Continuous Manufacturing of Pharmaceutical Materials
- Melt Extrusion and Continuous Manufacturing of Pharmaceutical Materials
- Continuous reactors for pharmaceutical manufacturing
- Recent regulatory status in continuous manufacturing
- Continuous Manufacturing equipment change over time
- Capacity planning for continuous pharmaceutical manufacturing facilities
- Continuous modified release coating equipment
- Continuous fluid-bed coating
- Continuous tablet-coating
- Continuous lyophilization
2024 Speakers Included
Joe Della Rocca, PhD
Associate Principal Scientist
Merck
Anand Uhbe, PhD
Senior Scientist (II), Sterile Liquids Product Development
Abbvie
Dipy Vasa, PhD
Principal Scientist, Drug Product Dev
Pfizer
Ryan Pelis, PhD
Sr. Principal Scientist, Pharmacokinetic Sciences
Novartis
Kellyn Zagaja, PhD
Principal Scientist, Drug Product Design
Pfizer
Siddharth S. Kesharwani, PhD
Biopharmaceutics Scientist
Sanofi
Indrajit Ghosh, PhD
Scientific Director, Biologics Product Development
Bristol Myers Squibb
Aruna Railkar, PhD
Senior Research Fellow
Quotient Sciences
Seth Forster, PhD
Associate Principal Scientist
Merck
Girish Nihalani, PhD
Research Fellow, Product Development
Teva Pharmaceuticals
Liliana Miinea, PhD
Global Technology Manager, Pharmaceutical Excipients
Lubrizol
Kelly Zhang, PhD
Senior Scientist, Analytical Enabling Capabilities – MBC | Analytical Research & Development
Merck
Misha Murashov, PhD
Assoc Prin. Scientist, Sterile & Specialty Products BDB
Merck
Prajwal Thool
Scientist III, Drug Product Development
Genentech
Zafar Iqbal, PhD
Vice President & Head of Pharmaceutical Development
Glatt Group
Jim Baxter
NA Technical Business Development Manager
Lubrizol Life Science
Firouz Asgarzadeh, PhD
President of Consulting Services
OSD Pharmaceutical Solutions
Vivek Gupta, PhD
Associate Professor, Pharmaceutical Sciences
St. John’s University
Erica Schlesinger, PhD
Vice President of Technical Development
Seran Biosciences
Ketan Patel, PhD
Associate Professor of Pharmaceutics
St. John’s University
Previous Sponsors & Exhibitors
Download The Controlled Release Previous Attendee List
Partnering with the 2025 Summit will also help you:
- Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
- Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
- Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
- Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions
"*" indicates required fields
Registration Pricing:
Super Early-Bird
Register Before December 17, 2024
Regular Attendance
$800
3-for-2 Group Pack
$1600
On-Demand
$595
Early-Bird Rate
Register Before Jan 31, 2025
Regular Attendance
$1100
3-for-2 Group Pack
$2200
On-Demand
$595
ONSITE PRICING
Register March 22, 2025 Onwards
Regular Attendance
$1600
3-for-2 Group Pack
$3200
On-Demand
$795